SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-021877
Filing Date
2023-06-20
Accepted
2023-06-20 16:54:39
Documents
13
Period of Report
2023-06-14
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 43136
2 ex16-1.htm EX-16.1 5167
  Complete submission text file 0001493152-23-021877.txt   230003

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE hils-20230614.xsd EX-101.SCH 3242
4 XBRL LABEL FILE hils-20230614_lab.xml EX-101.LAB 34916
5 XBRL PRESENTATION FILE hils-20230614_pre.xml EX-101.PRE 22799
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3877
Mailing Address 245 MAIN STREET SUITE 204 CHESTER NJ 07930
Business Address 1200 ROUTE 22 EAST BRIDGEWATER NJ 08807 302-743-2995
Hillstream BioPharma Inc. (Filer) CIK: 0001861657 (see all company filings)

IRS No.: 842642541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41210 | Film No.: 231025990
SIC: 2834 Pharmaceutical Preparations